OFFIDANI, MASSIMO

OFFIDANI, MASSIMO  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.024 secondi).
Titolo Data di pubblicazione Autore(i) File
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 1-gen-2012 Cavo, M; Pantani, L; Petrucci, Mt; Patriarca, F; Zamagni, E; Donnarumma, D; Crippa, C; Boccadoro, M; Perrone, G; Falcone, A; Nozzoli, C; Zambello, R; Masini, L; Furlan, A; Brioli, A; Derudas, D; Ballanti, S; Dessanti, Ml; De Stefano, V; Carella, Am; Marcatti, M; Nozza, A; Ferrara, F; Callea, V; Califano, C; Pezzi, A; Baraldi, A; Grasso, M; Musto, P; Palumbo, A; GIMEMA Italian Myeloma, Network; Olivieri, Attilio; Offidani, Massimo; Leoni, Pietro
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 1-gen-2022 Morsia, E; Torre, E; Marrara, F; Battila, I; Fiorentini, A; Scortechini, Ar; Offidani, M; Svegliati-Baroni, G; Bendia, E; Olivieri, A; Tarantino, G; Rupoli, S
Current Main Topics in Multiple Myeloma 1-gen-2023 Morè, Sonia; Corvatta, Laura; Manieri, Valentina Maria; Olivieri, Attilio; Offidani, Massimo
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 1-gen-2012 Capelli, Debora; Chiarucci, Martina; Saraceni, Francesco; Poloni, Antonella; Montanari, Mauro; Offidani, Massimo; Rupoli, Serena; Scortechini, Anna Rita; Gini, Guido; Scortechini, Ilaria; Leoni, Pietro; Olivieri, Attilio
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 1-gen-2022 Morsia, E; Torre, E; Marrara, F; More, S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 1-gen-2016 Martino, M.; Lemoli, R. M; Girmenia, C; Castagna, L.; Bruno, B.; Cavallo, F.; Offidani, Massimo; Scortechini, Ilaria; Montanari, Mauro; Milone, G.; Postacchini, Laura; Olivieri, Attilio
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 1-gen-2022 Pagano, Livio; Criscuolo, Marianna; Broccoli, Alessandro; Piciocchi, Alfonso; Varettoni, Marzia; Galli, Eugenio; Anastasia, Antonella; Cantonetti, Maria; Trentin, Livio; Kovalchuk, Sofia; Orsucci, Lorella; Frustaci, Annamaria; Spolzino, Angelica; Volpetti, Stefano; Annibali, Ombretta; Storti, Sergio; Stelitano, Caterina; Marchesi, Francesco; Offidani, Massimo; Casadei, Beatrice; Nizzoli, Maria Elena; De Luca, Maria Lucia; Fianchi, Luana; Motta, Marina; Guarnera, Luca; Simonetti, Edoardo; Visentin, Andrea; Vassallo, Francesco; Deodato, Marina; Sarlo, Chiara; Olivieri, Attilio; Falini, Brunangelo; Pulsoni, Alessandro; Tiacci, Enrico; Zinzani, Pier Luigi
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 1-gen-2023 Morè, Sonia; Corvatta, Laura; Manieri, Valentina Maria; Morsia, Erika; Poloni, Antonella; Offidani, Massimo
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 1-gen-2022 Offidani, M; Zizzo, C; Rupoli, S; Federici, I; More, S; Bossi, A; Manieri, Vm; Petrucci, Mt; Di Toritto, Tc; Brunori, M; Gozzetti, A; Tordi, A; Fazio, F; Lisi, C; Melaccio, A; Ciuffreda, L; Falcone, Ap; Fioritoni, F; Gentili, S; Siniscalchi, A; Trastulli, F; Corvatta, L; Morsia, E; Olivieri, A; Duro, G
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 1-gen-2023 Morè, Sonia; Corvatta, Laura; Manieri, Maria Valentina; Olivieri, Attilio; Offidani, Massimo